Von Willebrand factor as a biomarker in systemic sclerosis.

被引：0
|
作者：
Barnes, T
Gliddon, AE
Dore, C
Moots, RJ
Maddison, P
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Univ Wales, Sch Sport & Exercise Sci, Bangor, Gwynedd, Wales
[3] MRC, Clin Trials Unit, London, England
[4] Ysbyty Gwynedd Hosp, Dept Rheumatol, Bangor, Gwynedd, Wales
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S588 / S588
页数：1
相关论文
共 50 条
  • [41] Mediastinal abnormalities in systemic sclerosis.
    Choe, W
    Mehlman, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (24): : 1771 - 1771
  • [42] Increased levels of hepatocyte growth factor in sera of patients with systemic sclerosis.
    Kawaguchi, Y
    Harigai, M
    Fukasawa, C
    Takagi, K
    Sugiura, T
    Ohta, S
    Hara, M
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S280 - S280
  • [43] von Willebrand factor
    Ruggeri, ZM
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (04): : 559 - 564
  • [44] Von Willebrand factor
    Bhogal, Pervinder
    Jensen, Melanie
    Hart, Dan
    Makalanda, Levansri
    Collins, George B.
    Spooner, Oliver
    Jaffer, Ounali
    CLINICAL MEDICINE, 2020, 20 (06) : E279 - E279
  • [45] von Willebrand factor
    Ruggeri, ZM
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (11): : S41 - S46
  • [46] Connective Tissue Growth Factor (CTGF) promoter polymorphism in systemic sclerosis.
    Fonseca, C
    Holmes, AM
    Welsh, K
    Abraham, D
    Black, CM
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S349 - S349
  • [47] Von Willebrand factor
    Ruggeri, ZM
    CURRENT OPINION IN HEMATOLOGY, 2003, 10 (02) : 142 - 149
  • [48] Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test
    Mori, Filippo
    Rossi, Paola
    Nardini, Ilaria
    Gambelli, Davide
    Farina, Claudio
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 221 - 228
  • [49] Proteome-Wide Analysis and CXCL4 As a Pathogenic Biomarker in Systemic Sclerosis.
    不详
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3319 - 3320
  • [50] Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease
    Batlle, Javier
    Fernanda Lopez-Fernandez, Maria
    Loures Fraga, Esther
    Rodriguez Trillo, Angela
    Almudena Perez-Rodriguez, Maria
    BLOOD COAGULATION & FIBRINOLYSIS, 2009, 20 (02) : 89 - 100
12345